Username

Password

Preview

Sign-in free and Explore the Exciting World of BiomedExperts:

Over 1.500.000 Profiles
More than 1.800 Organizations worldwide
State of the Art Network Visualizations

Manage your own Profile
Locate Experts in your Country/Region
Locate Experts in your 1. and 2. Level Network
Connect to Experts Worldwide

NetworkView

Frederick Valeriote

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Living Beings

Chemicals & Drugs

Physiology

Procedures

Disorders

Concepts & Ideas

Genes & Molecular Sequences

Molecular Structure

Anatomy

Phenomena

Drug Synergism

Sign-in to see full Profile

Sign-in to see all Coauthors

Publications

TOP 3
Robinson Sarah J; Hoobler Eric K; Riener Michelle; Loveridge Steven T; Tenney Karen; Valeriote Frederick A; Holman Theodore R; Crews Phillip
Using enzyme assays to evaluate the structure and bioactivity of sponge-derived meroterpenes.
Simmons T Luke; Nogle Lisa M; Media Joseph; Valeriote Frederick A; Mooberry Susan L; Gerwick William H
Desmethoxymajusculamide C, a cyanobacterial depsipeptide with potent cytotoxicity in both cyclic and ring-opened forms.
Amagata Taro; Johnson Tyler A; Cichewicz Robert H; Tenney Karen; Mooberry Susan L; Media Joseph; Edelstein Matthew; Valeriote Frederick A; Crews Phillip
Interrogating the bioactive pharmacophore of the latrunculin chemotype by investigating the metabolites of two taxonomically unrelated sponges.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Frederick Valeriote (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Robinson Sarah J; Hoobler Eric K; Riener Michelle; Loveridge Steven T; Tenney Karen; Valeriote Frederick A; Holman Theodore R; Crews Phillip
Using enzyme assays to evaluate the structure and bioactivity of sponge-derived meroterpenes.
Journal of natural products 2009;72(10):1857-63.
2009: Simmons T Luke; Nogle Lisa M; Media Joseph; Valeriote Frederick A; Mooberry Susan L; Gerwick William H
Desmethoxymajusculamide C, a cyanobacterial depsipeptide with potent cytotoxicity in both cyclic and ring-opened forms.
Journal of natural products 2009;72(6):1011-6.
2008: Amagata Taro; Johnson Tyler A; Cichewicz Robert H; Tenney Karen; Mooberry Susan L; Media Joseph; Edelstein Matthew; Valeriote Frederick A; Crews Phillip
Interrogating the bioactive pharmacophore of the latrunculin chemotype by investigating the metabolites of two taxonomically unrelated sponges.
Journal of medicinal chemistry 2008;51(22):7234-42.
2008: Johnson Tyler A; Amagata Taro; Oliver Allen G; Tenney Karen; Valeriote Frederick A; Crews Phillip
The unexpected isolation of CTP-431, a novel thiopyrone from the sponge Cacospongia mycofijiensis.
The Journal of organic chemistry 2008;73(18):7255-9.
2008: Clark Benjamin R; Engene Niclas; Teasdale Margaret E; Rowley David C; Matainaho Teatulohi; Valeriote Frederick A; Gerwick William H
Natural products chemistry and taxonomy of the marine cyanobacterium Blennothrix cantharidosmum.
Journal of natural products 2008;71(9):1530-7.
2008: Rubio Brent K; Robinson Sarah J; Avalos Claudia E; Valeriote Frederick A; de Voogd Nicole J; Crews Phillip
Revisiting the sponge sources, stereostructure, and biological activity of cyclocinamide a.
Journal of natural products 2008;71(8):1475-8.
2008: Loper Joyce E; Henkels Marcella D; Shaffer Brenda T; Valeriote Frederick A; Gross Harald
Isolation and identification of rhizoxin analogs from Pseudomonas fluorescens Pf-5 by using a genomic mining strategy.
Applied and environmental microbiology 2008;74(10):3085-93.
2008: Bowling John J; Pennaka Hari K; Ivey Kelly; Wahyuono Subagus; Kelly Michelle; Schinazi Raymond F; Valeriote Frederick A; Graves David E; Hamann Mark T
Antiviral and anticancer optimization studies of the DNA-binding marine natural product aaptamine.
Chemical biology & drug design 2008;71(3):205-15.
2007: Miyata Yoshinari; Diyabalanage Thushara; Amsler Charles D; McClintock James B; Valeriote Frederick A; Baker Bill J
Ecdysteroids from the Antarctic tunicate Synoicum adareanum.
Journal of natural products 2007;70(12):1859-64.
2007: Johnson Tyler A; Tenney Karen; Cichewicz Robert H; Morinaka Brandon I; White Kimberly N; Amagata Taro; Subramanian Balanehru; Media Joseph; Mooberry Susan L; Valeriote Frederick A; Crews Phillip
Sponge-derived fijianolide polyketide class: further evaluation of their structural and cytotoxicity properties.
Journal of medicinal chemistry 2007;50(16):3795-803.
2007: Robinson Sarah J; Tenney Karen; Yee Desiree F; Martinez Lizabeth; Media Joseph E; Valeriote Frederick A; van Soest Rob W M; Crews Phillip
Probing the bioactive constituents from chemotypes of the sponge Psammocinia aff. bulbosa.
Journal of natural products 2007;70(6):1002-9.
2007: Marshall James A; Sabatini Jesse J; Valeriote Frederick
ABC synthesis and antitumor activity of a series of Annonaceous acetogenin analogs with a threo, trans, threo, trans, threo-bis-tetrahydrofuran core unit.
Bioorganic & medicinal chemistry letters 2007;17(9):2434-7.
2007: Ralifo Paul; Sanchez Laura; Gassner Nadine C; Tenney Karen; Lokey R Scott; Holman Theodore R; Valeriote Frederick A; Crews Phillip
Pyrroloacridine alkaloids from Plakortis quasiamphiaster: structures and bioactivity.
Journal of natural products 2007;70(1):95-9.
2007: Ralifo Paul; Tenney Karen; Valeriote Frederick A; Crews Phillip
A distinctive structural twist in the aminoimidazole alkaloids from a calcareous marine sponge: isolation and characterization of leucosolenamines A and B.
Journal of natural products 2007;70(1):33-8.
2006: Amagata Taro; Morinaka Brandon I; Amagata Akiko; Tenney Karen; Valeriote Frederick A; Lobkovsky Emil; Clardy Jon; Crews Phillip
A chemical study of cyclic depsipeptides produced by a sponge-derived fungus.
Journal of natural products 2006;69(11):1560-5.
2006: Gross Harald; Goeger Douglas E; Hills Patrice; Mooberry Susan L; Ballantine David L; Murray Thomas F; Valeriote Frederick A; Gerwick William H
Lophocladines, bioactive alkaloids from the red alga Lophocladia sp.
Journal of natural products 2006;69(4):640-4.
2006: Sonnenschein Rachel N; Johnson Tyler A; Tenney Karen; Valeriote Frederick A; Crews Phillip
A reassignment of (-)-mycothiazole and the isolation of a related diol.
Journal of natural products 2006;69(1):145-7.
2006: Boot Claudia M; Tenney Karen; Valeriote Frederick A; Crews Phillip
Highly N-methylated linear peptides produced by an atypical sponge-derived Acremonium sp.
Journal of natural products 2006;69(1):83-92.
2006: Marshall James A; Mikowski Ann M; Bourbeau Matthew P; Schaaf Gregory M; Valeriote Frederick
Leptostatin: a synthetic hybrid of the cytotoxic polyketides callystatin A and leptomycin B.
Bioorganic & medicinal chemistry letters 2006;16(2):320-3.
2006: Subramanian Balanehru; Nakeff Alexander; Tenney Karen; Crews Phillip; Gunatilaka Leslie; Valeriote Fred
A new paradigm for the development of anticancer agents from natural products.
Journal of experimental therapeutics & oncology 2006;5(3):195-204.
2005: Christian Omar E; Compton Jennifer; Christian Keisha R; Mooberry Susan L; Valeriote Fredrick A; Crews Phillip
Using jasplakinolide to turn on pathways that enable the isolation of new chaetoglobosins from Phomospis asparagi.
Journal of natural products 2005;68(11):1592-7.
2005: Postema Maarten H D; Piper Jared L; Betts Russell L; Valeriote Frederick A; Pietraszkewicz Halina
RCM-based synthesis of a variety of beta-C-glycosides and their in vitro anti-solid tumor activity.
The Journal of organic chemistry 2005;70(3):829-36.
2004: Fu Xiong; Palomar Alana J; Hong Eugene P; Schmitz Francis J; Valeriote Frederick A
Cytotoxic lissoclimide-type diterpenes from the molluscs Pleurobranchusalbiguttatus and Pleurobranchus forskalii.
Journal of natural products 2004;67(8):1415-8.
2004: White James D; Xu Qing; Lee Chang-Sun; Valeriote Frederick A
Total synthesis and biological evaluation of +-kalkitoxin, a cytotoxic metabolite of the cyanobacterium Lyngbya majuscula.
Organic & biomolecular chemistry 2004;2(14):2092-102.
2004: Aron Zachary D; Pietraszkiewicz Halina; Overman Larry E; Valeriote Fredrick; Cuevas Carman
Synthesis and anticancer activity of side chain analogs of the crambescidin alkaloids.
Bioorganic & medicinal chemistry letters 2004;14(13):3445-9.
2004: Cichewicz Robert H; Valeriote Frederick A; Crews Phillip
Psymberin, a potent sponge-derived cytotoxin from Psammocinia distantly related to the pederin family.
Organic letters 2004;6(12):1951-4.
2004: Segraves Nathaniel L; Robinson Sarah J; Garcia Daniel; Said Sadri A; Fu Xiong; Schmitz Francis J; Pietraszkiewicz Halina; Valeriote Frederick A; Crews Phillip
Comparison of fascaplysin and related alkaloids: a study of structures, cytotoxicities, and sources.
Journal of natural products 2004;67(5):783-92.
2004: Gautschi Jeffrey T; Amagata Taro; Amagata Akiko; Valeriote Frederick A; Mooberry Susan L; Crews Phillip
Expanding the strategies in natural product studies of marine-derived fungi: a chemical investigation of penicillium obtained from deep water sediment.
Journal of natural products 2004;67(3):362-7.
2003: Amagata Taro; Amagata Akiko; Tenney Karen; Valeriote Frederick A; Lobkovsky Emil; Clardy Jon; Crews Phillip
Unusual C25 steroids produced by a sponge-derived Penicillium citrinum.
Organic letters 2003;5(23):4393-6.
2003: Amagata Taro; Rath Christopher; Rigot Jérôme F; Tarlov Nick; Tenney Karen; Valeriote Frederick A; Crews Phillip
Structures and cytotoxic properties of trichoverroids and their macrolide analogues produced by saltwater culture of Myrothecium verrucaria.
Journal of medicinal chemistry 2003;46(20):4342-50.
2003: Marshall James A; Piettre Arnaud; Paige Mikell A; Valeriote Frederick
Total synthesis and structure confirmation of the annonaceous acetogenins 30(S)-hydroxybullatacin, uvarigrandin a, and 5(R)-uvarigrandin a (narumicin I?).
The Journal of organic chemistry 2003;68(5):1780-5.
2003: Marshall James A; Piettre Arnaud; Paige Mikell A; Valeriote Frederick
A modular synthesis of annonaceous acetogenins.
The Journal of organic chemistry 2003;68(5):1771-9.
2002: Thale Zia; Johnson Tyler; Tenney Karen; Wenzel Philip J; Lobkovsky Emil; Clardy Jon; Media Joe; Pietraszkiewicz Halina; Valeriote Frederick A; Crews Phillip
Structures and cytotoxic properties of sponge-derived bisannulated acridines.
The Journal of organic chemistry 2002;67(26):9384-91.
2002: Subramanian Balanehru; Nakeff Alexander; Media Joseph E; Wiegand Richard A; Valeriote Frederick A
Inhibition of macromolecular synthesis by cryptophycin-52.
Anti-cancer drugs 2002;13(10):1061-8.
2002: Subramanian Balanehru; Nakeff Alexander; Media Joseph; Wentland Mark; Valeriote Frederick
Cellular drug action profile paradigm applied to XK469.
Journal of experimental therapeutics & oncology 2002;2(5):253-63.
2002: Valeriote Fred; Grieshaber Charles K; Media Joseph; Pietraszkewicz Halina; Hoffmann Joseph; Pan Meide; McLaughlin Steve
Discovery and development of anticancer agents from plants.
Journal of experimental therapeutics & oncology 2002;2(4):228-36.
2002: Lin Hong; Liu Xiang Y; Subramanian Balanehru; Nakeff Alexander; Valeriote Fred; Chen Ben D
Mitotic arrest induced by XK469, a novel antitumor agent, is correlated with the inhibition of cyclin B1 ubiquitination.
International journal of cancer. Journal international du cancer 2002;97(1):121-8.
1998: Harrigan G G; Yoshida W Y; Moore R E; Nagle D G; Park P U; Biggs J; Paul V J; Mooberry S L; Corbett T H; Valeriote F A
Isolation, structure determination, and biological activity of dolastatin 12 and lyngbyastatin 1 from Lyngbya majuscula/Schizothrix calcicola cyanobacterial assemblages.
Journal of natural products 1998;61(10):1221-5.
1998: Harrigan G G; Luesch H; Yoshida W Y; Moore R E; Nagle D G; Paul V J; Mooberry S L; Corbett T H; Valeriote F A
Symplostatin 1: A dolastatin 10 analogue from the marine cyanobacterium Symploca hydnoides.
Journal of natural products 1998;61(9):1075-7.
1998: Chen B D; Nakeff A; Valeriote F
Cellular uptake of a novel cytotoxic agent, cryptophycin-52, by human THP-1 leukemia cells and H-125 lung tumor cells.
International journal of cancer. Journal international du cancer 1998;77(6):869-73.
1998: Sperry S; Valeriote F A; Corbett T H; Crews P
Isolation and cytotoxic evaluation of marine sponge-derived norterpene peroxides.
Journal of natural products 1998;61(2):241-7.
1998: Foster B J; Fortuna M; Media J; Wiegand R A; Valeriote F A
Cryptophycin 1 cellular levels and effects in vitro using L1210 cells.
Investigational new drugs 1998;16(3):199-204.
1998: Valeriote F A; Corbett T H; Grieco P A; Moher E D; Collins J L; Fleck T J
Anticancer activity of glaucarubinone analogues.
Oncology research 1998;10(4):201-8.
1998: Edelstein M; Corbett T; Valeriote F
In vitro screening model for the detection of agents active against myelogenous leukemia.
Cancer investigation 1998;16(5):303-8.
1997: Corbett T H; Valeriote F A; Demchik L; Lowichik N; Polin L; Panchapor C; Pugh S; White K; Kushner J; Rake J; Wentland M; Golakoti T; Hetzel C; Ogino J; Patterson G; Moore R
Discovery of cryptophycin-1 and BCN-183577: examples of strategies and problems in the detection of antitumor activity in mice.
Investigational new drugs 1997;15(3):207-18.
1997: Polin L; Valeriote F; White K; Panchapor C; Pugh S; Knight J; LoRusso P; Hussain M; Liversidge E; Peltier N; Golakoti T; Patterson G; Moore R; Corbett T H
Treatment of human prostate tumors PC-3 and TSU-PR1 with standard and investigational agents in SCID mice.
Investigational new drugs 1997;15(2):99-108.
1997: Simon M S; Heilbrun L K; Boomer A; Kresge C; Depper J; Kim P N; Valeriote F; Martino S
A randomized trial of a low-fat dietary intervention in women at high risk for breast cancer.
Nutrition and cancer 1997;27(2):136-42.
1996: Nakeff A; KuKuruga M A; Media J E; Valeriote F; Edelstein M B
Quantitative measurements of the efficacy of new anti-cancer agents on fresh human AML cells by using multivariate flow analysis.
Journal of experimental therapeutics & oncology 1996;1(6):361-7.
1996: Corbett T H; Valeriote F A; Demchik L; Polin L; Panchapor C; Pugh S; White K; Knight J; Jones J; Jones L; LoRusso P; Foster B; Wiegand R A; Lisow L; Golakoti T; Heltzel C E; Ogino J; Patterson G M; Moore R E
Preclinical anticancer activity of cryptophycin-8.
Journal of experimental therapeutics & oncology 1996;1(2):95-108.
1996: Li Y; Valeriote F; Chen B
Regulation of granulocyte-macrophage colony-stimulating factor (GM-CSF) receptors in a GM-CSF-dependent human myeloid leukemia cell line (AML-193) by interleukin-6.
Experimental hematology 1996;24(2):94-100.
1996: Valeriote F; Corbett T; Edelstein M; Baker L
New in vitro screening model for the discovery of antileukemic anticancer agents.
Cancer investigation 1996;14(2):124-41.
1995: Djuric Z; Corbett T H; Valeriote F A; Heilbrun L K; Baker L H
Detoxification ability and toxicity of quinones in mouse and human tumor cell lines used for anticancer drug screening.
Cancer chemotherapy and pharmacology 1995;36(1):20-6.
1992: Djuric Z; Everett C K; Valeriote F A
DNA damage and cytotoxicity in L1210 cells by ellipticine and a structural analogue, N-2-(diethylaminoethyl)-9-hydroxyellipticinium chloride.
Cancer research 1992;52(6):1515-9.
1991: Djuric Z; Heilbrun L K; Reading B A; Boomer A; Valeriote F A; Martino S
Effects of a low-fat diet on levels of oxidative damage to DNA to human peripheral nucleated blood cells.
Journal of the National Cancer Institute 1991;83(11):766-9.
1990: Mucci-LoRusso P; Polin L; Biernat L A; Valeriote F A; Corbett T H
Activity of datelliptium acetate (NSC 311152; SR 95156A) against solid tumors of mice.
Investigational new drugs 1990;8(3):253-61.
1990: De Neve W; Evelhoch J; Everett C; Simpson N; Bissery M C; Corbett T; Valeriote F
Interaction between flavone acetic acid (LM-975, NSC 349512) and radiation in Glasgow's osteogenic sarcoma in vivo.
International journal of radiation oncology, biology, physics 1990;18(6):1359-65.
1990: DeNeve W; Valeriote F; Tapazoglou E; Everett C; Khatana A; Corbett T
Discrepancy between cytotoxicity and DNA interstrand crosslinking of carboplatin and cisplatin in vivo.
Investigational new drugs 1990;8(1):17-24.
1990: Edelstein M B; Crowley J J; Valeriote F A; Bonnet J D; Carden J O; Khanna R C; Salmon S E; Ungerleider J S
A-phase II study of intravenous 6-thioguanine (NSC-752) in multiple myeloma. A Southwest Oncology Group study.
Investigational new drugs 1990;8 Suppl 1():S83-6.
1990: Brodfuehrer J; Valeriote F; Chan K; Heilbrun L; Corbett T
Flavone acetic acid and plasma protein binding.
Cancer chemotherapy and pharmacology 1990;27(1):27-32.
1989: Valeriote F; Grates H E
Potentiation of nitrogen mustard cytotoxicity by disulfiram, diethyldithiocarbamic acid, and diethylamine in mice.
Cancer research 1989;49(23):6658-61.
1989: Mucci-LoRusso P; Polin L; Bissery M C; Valeriote F; Plowman J; Luk G D; Corbett T H
Activity of batracylin (NSC-320846) against solid tumors of mice.
Investigational new drugs 1989;7(4):295-306.
1989: DeNeve W; Valeriote F; Edelstein M; Everett C; Bischoff M
In vivo DNA cross-linking by cyclophosphamide: comparison of human chronic lymphatic leukemia cells with mouse L1210 leukemia and normal bone marrow cells.
Cancer research 1989;49(13):3452-6.
1989: Ataya K M; Valeriote F A; Ramahi-Ataya A J
Effect of cyclophosphamide on the immature rat ovary.
Cancer research 1989;49(7):1660-4.
1989: Chabot G G; Pazdur R; Valeriote F A; Baker L H
Pharmacokinetics and toxicity of continuous infusion amphotericin B in cancer patients.
Journal of pharmaceutical sciences 1989;78(4):307-10.
1989: Thrush G R; Placey J L; Valeriote F A; Lerman S P
The CD4 cell dependency of SJL/J B-cell lymphomas as a target for cyclophosphamide therapy.
Cancer communications 1989;1(5):301-10.
1988: DeNeve W J; Everett C K; Suminski J E; Valeriote F A
Influence of WR2721 on DNA cross-linking by nitrogen mustard in normal mouse bone marrow and leukemia cells in vivo.
Cancer research 1988;48(21):6002-5.
1988: Brown J M; Hall E J; Hirst D G; Kinsella T J; Kligerman M M; Mitchell J B; Travis E J; Valeriote F
Chemical modification of radiation and chemotherapy.
American journal of clinical oncology 1988;11(3):288-303.
1988: Bissery M C; Valeriote F A; Chabot G G; Crissman J D; Yost C; Corbett T H
Flavone acetic acid (NSC 347512)-induced DNA damage in Glasgow osteogenic sarcoma in vivo.
Cancer research 1988;48(5):1279-85.
1987: O'Dwyer P J; Shoemaker D; Zaharko D S; Grieshaber C; Plowman J; Corbett T; Valeriote F; King S A; Cradock J; Hoth D F
Flavone acetic acid (LM 975, NSC 347512). A novel antitumor agent.
Cancer chemotherapy and pharmacology 1987;19(1):6-10.
1987: Corbett T H; Valeriote F A; Baker L H
Is the P388 murine tumor no longer adequate as a drug discovery model?
Investigational new drugs 1987;5(1):3-20.
1986: Valeriote F; Grates H E
Potentiation of nitrogen mustard cytotoxicity to leukemia cells by sulfur-containing compounds administered in vivo.
International journal of radiation oncology, biology, physics 1986;12(7):1165-9.
1986: Valeriote F; Dieckman J; Chabot G
Schedule-dependent potentiation of lomustine cytotoxicity by amphotericin B in mice.
Journal of the National Cancer Institute 1986;76(3):521-5.
1986: Valeriote F; Grates H
MOPC-315 murine plasmacytoma as a model anticancer screen for human multiple myeloma.
Journal of the National Cancer Institute 1986;76(1):61-5.
1986: Santelli G; Valeriote F
Schedule-dependent cytotoxicity of 5-fluorouracil in mice.
Journal of the National Cancer Institute 1986;76(1):159-64.
1986: Santelli G; Valeriote F
Schedule-dependent antitumor and toxic effects of thymidine and 5-fluorouracil in AKR and L1210 leukemias.
Cancer chemotherapy and pharmacology 1986;18(2):101-4.
1986: Corbett T H; Bissery M C; Wozniak A; Plowman J; Polin L; Tapazoglou E; Dieckman J; Valeriote F
Activity of flavone acetic acid (NSC-347512) against solid tumors of mice.
Investigational new drugs 1986;4(3):207-20.
1985: Edelstein M; Valeriote F
Cytosine arabinoside in experimental combination therapy.
Seminars in oncology 1985;12(2 Suppl 3):75-83.
1985: Clamon G; Chabot G G; Valeriote F; Davilla E; Vogel C; Gorowski E; Birch R
Phase I study and pharmacokinetics of weekly high-dose 13-cis-retinoic acid.
Cancer research 1985;45(4):1874-8.
1985: Valeriote F; Vietti T
Comparison of cytotoxicity of single dose and infusion of alkylating agents.
Cancer drug delivery 1985;2(1):11-8.
1985: Valeriote F; Muntz I D; Vietti T J
Survival of L1210 leukemia cells and normal hematopoietic stem cells following in vivo administration of cyclocytidine.
Investigational new drugs 1985;3(3):255-61.
1984: Valeriote F; Grates H E
Dose and interval relationship for the interaction of WR-2721 and nitrogen mustard with normal and malignant cells.
International journal of radiation oncology, biology, physics 1984;10(9):1561-4.
1984: Valeriote F; Medoff G; Tolen S; Dieckman J
Amphotericin B potentiation of the cytotoxicity of anticancer agents against both normal hematopoietic and leukemia cells in mice.
Journal of the National Cancer Institute 1984;73(2):475-82.
1984: Flentje D; Flentje M; Valeriote F; Sapareto S
Analysis of MOPC-315 plasmacytoma by elutriation and flow cytometry.
Cell and tissue kinetics 1984;17(2):171-83.
1984: Valeriote F; Medoff G; Dieckman J
Potentiation of cytotoxicity of anticancer agents by several different polyene antibiotics.
Journal of the National Cancer Institute 1984;72(2):435-9.
1984: Valeriote F; Dieckman J; Flentje D; Flentje M; Medoff G
Potentiation by amphotericin B of the cytotoxicity of anticancer agents against MOPC-315 plasmacytoma and Lewis lung carcinoma.
Cancer chemotherapy and pharmacology 1984;13(2):126-30.
1984: Valeriote F; Santelli G
5-Fluorouracil (FUra).
Pharmacology & therapeutics 1984;24(1):107-32.
1983: Valeriote F; Tolen S
Extensive proliferative capacity of haematopoietic stem cells.
Cell and tissue kinetics 1983;16(1):1-5.
1982: Valeriote F; Tolen S
Protection and potentiation of nitrogen mustard cytotoxicity by WR-2721.
Cancer research 1982;42(11):4330-1.
1982: Valeriote F
Cellular aspects of the action of cytosine arabinoside.
Medical and pediatric oncology 1982;10 Suppl 1():5-26.
1981: Presant C A; Vietti T J; Valeriote F; Coulter D M
Chemotherapy of L1210 leukemia with 5-azacytidine in combination with vincristine, adriamycin, or beta-cytosine arabinoside.
Journal of the National Cancer Institute 1981;67(6):1283-8.
1981: Medoff G; Valeriote F; Dieckman J
Potentiation of anticancer agents by amphotericin B.
Journal of the National Cancer Institute 1981;67(1):131-5.
1981: Santelli G; Valeriote F; Vietti T; Coulter D
Cytotoxic effect of 5-fluorouracil plus cyclophosphamide against transplantable leukemias.
European journal of cancer 1981;17(6):629-34.
1981: Valeriote F; Lynch R; Berger N A; White E; Coulter D
Growth characteristics of MOPC-315 plasmacytoma and response to anticancer agents.
Journal of the National Cancer Institute 1981;66(6):1083-8.
1981: Presant C A; Coulter D; Valeriote F; Vietti T J
Contrasting cytotoxicity kinetics of 5-azacytidine and dihydro-5-azacytidine hydrochloride in L1210 leukemia in mice.
Journal of the National Cancer Institute 1981;66(6):1151-4.
1981: Phelan E T; Vietti T J; Valeriote F A; Coulter D
Comparison of cytotoxic action of iphosphamide and cyclophosphamide.
Anticancer research 1981;1(3):149-54.
1980: Razek A; Valeriote F; Vietti T
Effect of dose fractionation of daunorubicin on survival of leukemic cells.
Cancer research 1980;40(8 Pt 1):2835-8.
1980: Valeriote F; Vietti T; Coulter D
Cytotoxicity of adriamycin combined with methotrexate against L1210 leukemia in mice.
Journal of the National Cancer Institute 1980;64(4):801-5.
1980: Santelli G; Valeriote F
In vivo potentiation of 5-fluorouracil cytotoxicity against AKR leukemia by purines, pyrimidines, and their nucleosides and deoxynucleosides.
Journal of the National Cancer Institute 1980;64(1):69-72.
1979: Valeriote F; Medoff G; Dieckman J
Potentiation of anticancer agent cytotoxicity against sensitive and resistant AKR leukemia by amphotericin B1.
Cancer research 1979;39(6 Pt 1):2041-5.
1979: Nakeff A; Valeriote F; Gray J W; Grabske R J
Application of flow cytometry and cell sorting to megakaryocytopoiesis.
Blood 1979;53(4):732-45.
1979: Valeriote F A
The use of cell kinetics in the development of drug combinations.
Pharmacology & therapeutics 1979;4(1):1-33.
1978: Stewart C C; Valeriote F A; Perez C A
Preliminary observations on the effect of glucan in combination with radiation and chemotherapy in four murine tumors.
Cancer treatment reports 1978;62(11):1867-72.
1978: Vietti T J; Valeriote F A; Kalish R; Coulter D
Kinetics of cytotoxicity of VM-26 and VP-16-213 on L1210 leukemia and hematopoietic stem cells.
Cancer treatment reports 1978;62(9):1313-20.
1978: Santelli G; Valeriote F
In vivo enhancement of 5-fluorouracil cytotoxicity to AKR leukemia cells by thymidine in mice.
Journal of the National Cancer Institute 1978;61(3):843-7.
1978: Valeriote F; Lynch R; Medoff G; Tolen S; Dieckman J
Growth and rejection of leukemia cells in individual mice after combined treatment with amphotericin B and 1,3-bis(2-chloroethyl)-1-nitrosourea.
Journal of the National Cancer Institute 1978;61(2):399-402.
1978: Nakeff A; Valeriote F A
Effect of a transplantable leukemia on hematopoietic stem cells in AKR mice.
Cancer treatment reports 1978;62(5):737-41.
1978: Edelstein M; Valeriote F; Vietti T
Influence of continuous infusion of cytosine arabinoside on sequencing with daunorubicin in L1210 leukemia.
Cancer treatment reports 1978;62(4):547-8.
1977: Valeriote F A; Edelstein M B
The role of cell kinetics in cancer chemotherapy.
Seminars in oncology 1977;4(2):217-26.
1977: Medoff G; Valeriote F; Ryan J; Tolen S
Response of transplanted AKR leukemia to combination therapy with amphotericin B and 1,3-bis(2-chloroethyl)-1-nitrosourea: dose and schedule dependency.
Journal of the National Cancer Institute 1977;58(4):949-53.
1977: Edelstein M; Valeriote F; Vietti T
Cellular quantitation of in vivo effects of 1-beta-D-arabinofuranosylcytosine on leukemia L1210.
Journal of the National Cancer Institute 1977;58(4):941-7.
1977: Edelstein M; Valeriote F
Retention of 1-beta-D-arabinofuranosylcytosine in vitro--a source of experimental error.
Biochemical pharmacology 1977;26(6):477-80.
1977: Presant C A; Valeriote F; Vietti T J
Biological characterization of a prolonged antileukemic effect of 5-azacytidine.
Cancer research 1977;37(2):376-81.
1976: Valeriote F; Vietti T; Edelstein M
Combined effect of cytosine arabinoside and thiopurines.
Cancer treatment reports 1976;60(12):1925-34.
1976: Ducos R; Valeriote F
Quantitation of the immune rejection of allotransplanted AKR leukemic cells.
Transplantation 1976;21(4):279-81.
1976: Valeriote F; Lynch R; Medoff G; Kumar B V
Protective effects of amphotericin B against spontaneous and transplantable murine tumors.
Journal of the National Cancer Institute 1976;56(3):557-60.
1976: Vietti T J; Valeriote F A
Conceptual basis for use of chemotherapeutic agents and their pharmacology.
Pediatric clinics of North America 1976;23(1):67-92.
1975: Graff R J; Valeriote F; Medoff G
Marked histoincompatibility between and within sublines of AKR mice used in a syngeneic leukemia model.
Journal of the National Cancer Institute 1975;55(4):1015-6.
1975: Valeriote F; van Putten L
Proliferation-dependent cytotoxicity of anticancer agents: a review.
Cancer research 1975;35(10):2619-30.
1975: Lynch R G; Medoff G; Valeriote F
A murine model for central nervous system leukemia and its possible relevance to human leukemia.
Journal of the National Cancer Institute 1975;55(3):611-7.
1975: Presant C A; Vietti T; Valeriote F
Kinetics of both leukemic and normal cell population reduction following 5-azacytidine.
Cancer research 1975;35(8):1926-30.
1975: Edelstein M; Vietti T; Valeriote F
The enhanced cytotoxicity of combinations of 1-beta-D-arabinofuranosylcytosine and methotrexate.
Cancer research 1975;35(6):1555-8.
1974: Razek A; Vietti T; Valeriote F
Optimum time sequence for the administration of vincristine and cyclophosphamide in vivo.
Cancer research 1974;34(8):1857-61.
1974: Medoff G; Valeriote F; Lynch R G; Schlessinger D; Kobayashi G S
Synergistic effect of amphotericin B and 1,3-bis(2-chloroethyl)-1-nitrosourea against a transplantable AKR leukemia.
Cancer research 1974;34(5):974-8.
1974: Edelstein M; Vietti T; Valeriote F
Schedule-dependent synergism for the combination of 1-beta-D-arabinofuranosylcytosine and daunorubicin.
Cancer research 1974;34(2):293-7.
1973: Razek A; Valeriote F; Vietti T
Survival of hematopoietic and leukemic colony-forming cells in vivo after administration of mitomycin C or porfiromycin.
Journal of the National Cancer Institute 1973;51(6):1845-8.
1973: Valeriote F; Vietti T; Tolen S
Kinetics of the lethal effect of actinomycin D on normal and leukemic cells.
Cancer research 1973;33(11):2658-61.
1972: Razek A; Valeriote F; Vietti T
Survival of hematopoietic and leukemic colony-forming cells in vivo following the administration of daunorubicin or adriamycin.
Cancer research 1972;32(7):1496-500.
1972: Valeriote F A; Tolen S J
Survival of hematopoietic and lymphoma colony-forming cells in vivo following the administration of a variety of alkylating agents.
Cancer research 1972;32(3):470-6.
1971: Vietti T; Eggerding F; Valeriote F
Combined effect of x radiation and 5-fluorouracil on survival of transplanted leukemic cells.
Journal of the National Cancer Institute 1971;47(4):865-70.
1971: Vietti T; Valeriote F
Actinomycin D: kinetics of its lethal action on a transplantable leukemia.
Journal of the National Cancer Institute 1971;46(6):1177-81.
1970: Auricchio F; Valeriote F; Tomkins G; Riley W D
Studies on the structure of tyrosine aminotransferase.
Biochimica et biophysica acta 1970;221(2):307-13.
1969: Valeriote F A; Auricchio F; Tomkins G M; Riley D
Purification and properties of rat liver tyrosine aminotransferase.
The Journal of biological chemistry 1969;244(13):3618-24.
1969: Bruce W R; Meeker B E; Powers W E; Valeriote F A
Comparison of the dose- and timesurvival curves for normal hematopoietic and lymphoma colony-forming cells exposed to vinblastine, vincristine, arabinosylcytosine, and amethopterin.
Journal of the National Cancer Institute 1969;42(6):1015-25.
1969: Borsa J; Whitmore G F; Valeriote F A; Collins D; Bruce W R
Studies on the persistence of methotrexate, cytosine arabinoside, and leucovorin in serum of mice.
Journal of the National Cancer Institute 1969;42(2):235-42.
1968: Bergsagel D E; Valeriote F A
Growth characteristics of a mouse plasma cell tumor.
Cancer research 1968;28(11):2187-96.
1968: Baker D G; Valeriote F A
The effect of x-irradiation and thermal burn on the intestinal mucosa.
Canadian journal of physiology and pharmacology 1968;46(3):533-6.
1968: Valeriote F A; Bruce W R; Meeker B E
Synergistic action of cyclophosphamide and 1,3-bis(2-chloroethyl)-1-nitrosourea on a transplanted murine lymphoma.
Journal of the National Cancer Institute 1968;40(5):935-44.
1968: Valeriote F A; Collins D C; Bruce W R
Hematological recovery in the mouse following single doses of gamma radiation and cyclophosphamide.
Radiation research 1968;33(3):501-11.
1967: Valeriote F A; Bruce W R
Comparison of the sensitivity of hematopoietic colony-forming cells in different proliferative states to vinblastine.
Journal of the National Cancer Institute 1967;38(3):393-9.
1966: Bruce W R; Meeker B E; Valeriote F A
Comparison of the sensitivity of normal hematopoietic and transplanted lymphoma colony-forming cells to chemotherapeutic agents administered in vivo.
Journal of the National Cancer Institute 1966;37(2):233-45.
1966: Baker D G; Valeriote F A
Effects of thermal burn and x-irradiation on early mortality.
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.) 1966;121(4):1275-9.
1966: Valeriote F A; Bruce W R; Meeker B E
A model for the action of vinblastine in vivo.
Biophysical journal 1966;6(2):145-52.
1966: Valeriote F A; Bruce W R; Meeker B E
Comparison of the sensitivity of normal hematopoietic and transplanted lymphoma colony-forming cells of mice to vinblastine administered in vivo.
Journal of the National Cancer Institute 1966;36(1):21-7.
1965: Valeriote F A; Bruce W R
An in vitro assay for growth-inhibiting activity of vinblastine.
Journal of the National Cancer Institute 1965;35(5):851-6.
1964: VALERIOTE F A; BAKER D G
THE COMBINED EFFECTS OF THERMAL TRAUMA AND X-IRRADIATION ON EARLY MORTALITY.
Radiation research 1964;22():693-702.

Sign-in to see more

Sign-in free and Explore the Exciting World of BiomedExperts:

NetworkView

Frederick Valeriote

Research Profile (preview)

Living Beings

Chemicals & Drugs

Physiology

Procedures

Disorders

Concepts & Ideas

Genes & Molecular Sequences

Anatomy

Phenomena

Network (preview)

Publications

Sign in free and see...

Visualized networks:

GeoTargeted Searches:

Research Profiles:

Geonetwork of Frederick Valeriote (preview)

All Publications